Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Diamyd_Medical> ?p ?o }
Showing triples 1 to 45 of
45
with 100 triples per page.
- Diamyd_Medical abstract "Diamyd Medical AB (OMX: DIAM B) is a Swedish medical research company, listed on the Stockholm Stock Exchange. Diamyd's research utilises two different platform technologies. One is based on the GAD65 molecule, which is used in a vaccine that has proven effective in delaying the destruction of beta cells associated with type 1 diabetes, the other on a system to deliver substances directly to nerve cells. The use of GAD65 for therapeutic purposes is licensed from the University of California, Los Angeles. In March, 2008 Diamyd's application for a phase III trial in the United States was approved by the U.S. Food and Drug Administration. The company will perform a parallel phase III trial in Europe.".
- Diamyd_Medical wikiPageExternalLink www.diamyd.com.
- Diamyd_Medical wikiPageID "14109656".
- Diamyd_Medical wikiPageLength "5708".
- Diamyd_Medical wikiPageOutDegree "24".
- Diamyd_Medical wikiPageRevisionID "618553309".
- Diamyd_Medical wikiPageWikiLink Autoantigen.
- Diamyd_Medical wikiPageWikiLink Autoimmunity.
- Diamyd_Medical wikiPageWikiLink Beta_cell.
- Diamyd_Medical wikiPageWikiLink Beta_cells.
- Diamyd_Medical wikiPageWikiLink Category:Pharmaceutical_companies_of_Sweden.
- Diamyd_Medical wikiPageWikiLink Clinical_trial.
- Diamyd_Medical wikiPageWikiLink Diabetes_mellitus_type_1.
- Diamyd_Medical wikiPageWikiLink Food_and_Drug_Administration.
- Diamyd_Medical wikiPageWikiLink GAD65.
- Diamyd_Medical wikiPageWikiLink Glutamate_decarboxylase.
- Diamyd_Medical wikiPageWikiLink Latent_autoimmune_diabetes.
- Diamyd_Medical wikiPageWikiLink Latent_autoimmune_diabetes_of_adults.
- Diamyd_Medical wikiPageWikiLink Mercodia.
- Diamyd_Medical wikiPageWikiLink NeuroLogix.
- Diamyd_Medical wikiPageWikiLink Parkinsons_disease.
- Diamyd_Medical wikiPageWikiLink Placebo.
- Diamyd_Medical wikiPageWikiLink Protein_Sciences.
- Diamyd_Medical wikiPageWikiLink Stockholm_Stock_Exchange.
- Diamyd_Medical wikiPageWikiLink Type_1_diabetes.
- Diamyd_Medical wikiPageWikiLink U.S._Food_and_Drug_Administration.
- Diamyd_Medical wikiPageWikiLink University_of_California,_Los_Angeles.
- Diamyd_Medical wikiPageWikiLinkText "Diamyd Medical".
- Diamyd_Medical hasPhotoCollection Diamyd_Medical.
- Diamyd_Medical wikiPageUsesTemplate Template:OMX.
- Diamyd_Medical wikiPageUsesTemplate Template:Reflist.
- Diamyd_Medical subject Category:Pharmaceutical_companies_of_Sweden.
- Diamyd_Medical hypernym Company.
- Diamyd_Medical type Company.
- Diamyd_Medical type Drug.
- Diamyd_Medical type Company.
- Diamyd_Medical type Drug.
- Diamyd_Medical comment "Diamyd Medical AB (OMX: DIAM B) is a Swedish medical research company, listed on the Stockholm Stock Exchange. Diamyd's research utilises two different platform technologies. One is based on the GAD65 molecule, which is used in a vaccine that has proven effective in delaying the destruction of beta cells associated with type 1 diabetes, the other on a system to deliver substances directly to nerve cells.".
- Diamyd_Medical label "Diamyd Medical".
- Diamyd_Medical sameAs m.03cty_0.
- Diamyd_Medical sameAs Diamyd_Medical.
- Diamyd_Medical sameAs Q5271033.
- Diamyd_Medical sameAs Q5271033.
- Diamyd_Medical wasDerivedFrom Diamyd_Medical?oldid=618553309.
- Diamyd_Medical isPrimaryTopicOf Diamyd_Medical.